CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)
$4.35 -0.04 (-0.9112%)
Analysed CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) News Sources
Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering
12-04-2026
yahoo.com
How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data
10-04-2026
yahoo.com
CytomX Therapeutics (CTMX) Making Progress on Key Metastatic Colorectal Cancer Treatment
06-04-2026
yahoo.com
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?
01-04-2026
yahoo.com
CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress
27-03-2026
yahoo.com
How The CytomX Therapeutics (CTMX) Narrative Is Shifting With New Colorectal Cancer Data
26-03-2026
yahoo.com
A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results
21-03-2026
yahoo.com
Jefferies Raises CytomX Therapeutics (CTMX) Price Target to $16
20-03-2026
yahoo.com
Sector Update: Health Care Stocks Slip Late Afternoon
18-03-2026
yahoo.com
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
18-03-2026
yahoo.com
What is the current price of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The current price of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is $4.35.
CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) since the previous trading day is $-0.04.
CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) since the previous trading day is -0.9112%.
What is the most recent average sentiment score for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The most recent average sentiment score for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)?
The most recent sentiment for CYTOMX THERAPEUTICS INC (CTMX:NASDAQ) is .
SEC-8K** Filing Available For CYTOMX THERAPEUTICS INC (CTMX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.